Mentice AB logo

Mentice AB (MN2)

Market Open
12 Aug, 06:08
XFRA XFRA
1. 27
+0.01
+0.3953%
34.31M Market Cap
406.67 P/E Ratio
- Div Yield
820 Volume
0.78 Eps
1.26
Previous Close
Add Transaction
Day Range
1.27 1.27
Year Range
0.8 1.42
Want to track MN2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

MN2 trading today higher at €1.27, an increase of 0.3953% from yesterday's close, completing a monthly increase of 9.0129% or €0.1. Over the past 12 months, MN2 stock gained 5.3942%.
MN2 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

MN2 Chart

People also search for

DCV
Advanex Inc.
13.2
-2.9412%
OKYO Pharma Limited
1.36
0%
78W
Modulight Oyj
1.04
-0.9524%
3NQ
Nano mRNA Co., Ltd.
0.55
0%
PGT
StrongPoint ASA
0.84
-0.4751%

Mentice AB (MN2) FAQ

What is the stock price today?

The current price is €1.27.

On which exchange is it traded?

Mentice AB is listed on XFRA.

What is its stock symbol?

The ticker symbol is MN2.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 34.31M.

Has Mentice AB ever had a stock split?

No, there has never been a stock split.

Mentice AB Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Frans Matthieu Venker CEO
XFRA Exchange
SE0012673291 ISIN
DE Country
124 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Mentice AB (publ), headquartered in Gothenburg, Sweden since its inception in 1998, stands at the forefront of endovascular simulation technology solutions. Catering to a wide geographical range that includes Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas, the company services the Medical Device Industry, Healthcare Systems, and maintains Strategic Alliances. Through its innovative approach, Mentice specializes in software modules and medical simulation tools that aid in the training and development of endovascular procedures, offering a comprehensive solution to improve clinical outcomes.

Products and Services

  • Software Modules - Mentice provides a diverse suite of software modules catering to various areas such as acute ischemic stroke intervention, atrial septal defect and patent foramen ovale occlusion, and more. Each module is designed to offer detailed simulations for specific endovascular procedures, thereby assisting in the training and proficiency of healthcare professionals in these complex interventions.
  • Medical Simulators for Endovascular Therapies - These simulators are sophisticated devices that replicate the human vascular system, providing an immersive training environment for medical practitioners to hone their operative skills without the risk to actual patients.
  • Simulator Accessories and Extensions - To complement the simulators, Mentice offers a range of accessories and extensions that enhance the simulation experience, including silicone vasculature models and flow systems for both cardiac and vascular applications.
  • Neurovascular Flow Systems - Specifically designed for neurovascular training, these flow systems simulate the cerebral vasculature, offering an advanced training tool for procedures like coiling and thrombectomy.
  • Mentice Right Heart Cath App - This mobile application provides an interactive platform for real-time exploration and learning of the right heart catheterization procedure, making it accessible and convenient for medical professionals on the go.
  • Mentice Live Learning Center - A cloud-based learning platform that serves both the medical technology industry and healthcare providers, offering access to a wide range of learning materials and simulation activities designed to improve procedural knowledge and skills.
  • Angio Suites and Robotic Integrators - Mentice offers integration solutions for angio suites and robotic assisted interventions, enabling a seamless transition into the use of advanced technology in endovascular procedures.

Contact Information

Address: Odinsgatan 10, Gothenburg, Sweden, 411 03
Phone: 46 20 38 85 16 01